Clinical Trial: A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy Volunteers
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of REGN17092, an Anti-SARS-CoV-2 (COVID-19) Monoclonal Antibody,
Brief Summary:
The purpose of this study is to learn about the safety and tolerability of different doses of REGN17092 administered with a needle either under the skin (called "subcutaneous") or into a vein (called an "infusion") in healthy participants.This is the first time that REGN17092 will be given to people.Other aims are to assess:How much of the study drug is in the blood at different timesWhether the body makes its own antibodies against the study drug (which could make the drug less effective or…
Read more